Tinka Resources Limited (TSXV:TK)

Longboard Pharmaceuticals Balance Sheet

Financials in millions CAD. Fiscal year is October - September.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Cash & Equivalents	1.89	2.08	7.48	9.6	4.04	12.87
Cash & Short-Term Investments	1.89	2.08	7.48	9.6	4.04	12.87
Cash Growth	-59.69%	-72.26%	-22.00%	137.41%	-68.58%	87.50%
Other Receivables	0.01	0.01	0.02	0.01	0.02	0.01
Receivables	0.01	0.01	0.02	0.01	0.02	0.01
Prepaid Expenses	0.07	0.14	0.08	0.12	0.09	0.07
Restricted Cash	-	-	-	8.22	7.64	8
Total Current Assets	1.97	2.22	7.59	17.95	11.79	20.94
Property, Plant & Equipment	74.05	72.81	68.88	59.94	55.32	48.37
Total Assets	76.03	75.03	76.47	77.9	67.11	69.31
Accounts Payable	0.32	0.43	0.65	0.64	0.59	0.78
Accrued Expenses	0	0	0	0	0.01	0.01
Other Current Liabilities	-	-	-	0.01	0	-
Total Current Liabilities	0.33	0.44	0.66	0.65	0.6	0.78
Total Liabilities	0.33	0.44	0.66	0.65	0.6	0.78
Common Stock	106.23	104.52	104.52	104.52	93.48	93.48
Retained Earnings	-38.35	-37.75	-36.52	-35.06	-34.14	-32.09
Comprehensive Income & Other	7.81	7.81	7.81	7.78	7.18	7.14
Shareholders' Equity	75.7	74.59	75.81	77.24	66.51	68.53
Total Liabilities & Equity	76.03	75.03	76.47	77.9	67.11	69.31
Net Cash (Debt)	1.89	2.08	7.48	9.6	4.04	12.87
Net Cash Growth	-59.69%	-72.26%	-22.00%	137.41%	-68.58%	87.50%
Net Cash Per Share	0.00	0.01	0.02	0.03	0.01	0.04
Filing Date Shares Outstanding	408.7	408.7	391.3	391.3	340.74	340.74
Total Common Shares Outstanding	408.7	391.3	391.3	391.3	340.74	340.74
Working Capital	1.65	1.78	6.93	17.3	11.2	20.16
Book Value Per Share	0.19	0.19	0.19	0.20	0.20	0.20
Tangible Book Value	75.7	74.59	75.81	77.24	66.51	68.53
Tangible Book Value Per Share	0.19	0.19	0.19	0.20	0.20	0.20
Machinery	0.21	0.21	0.21	0.18	0.28	0.27

Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.